Oosterveer, D.M.

–Š‡ ƒ† patient ™‹–Š study angiotensin polymorphism xanthoma ”‹• disease ƒ••‘…‹ƒ–‡† ’ƒ–‹‡–• –Šƒ– ™ƒ• statin ˆ‘” šƒ–Š‘ƒ• statin treatment ™‡”‡ hypercholesterolemia ’”‡•‡…‡ cholesterol heart Š‡ treatment atherosclerosi association ‘– population effect angiotensin ii receptor level fh patients –Š‹• …ƒ”†‹‘˜ƒ•…—Žƒ” –Š‡•‡ ƒ”‡ …Ž‹‹…ƒŽ ‰‡‡–‹… kastelein jj result ’‘Ž›‘”’Š‹•• presence heart disease alox 5ap gene ˆƒ…–‘”• ™Š‹…Š angiotensin iii chd risk ƒ••‘…‹ƒ–‹‘ allele genotype journal •–—†› „‡–™‡‡ pathway ‘—” model ˆ”‘ tendon xanthomas •–—†‹‡• ‰‡‡ angiotensin iv ƒ••‘…‹ƒ–‹‘• table Šƒ† Šƒ˜‡ Š‹‰Š‡” ‡ˆˆ‡…– haplotype …Š‘Ž‡•–‡”‘Ž variant •‹‰‹ˆ‹…ƒ–Ž› signi analyses mutation analysis lipoprotein •–ƒ–‹